Rob Duncombe

The Christie NHS Foundation Trust
Director of Pharmacy

Rob Duncombe. Director of Pharmacy at the Christie NHS Foundation Trust in Manchester. A member of a number of national groups associated with pharmacy practice and medicines optimisation. Closely involved in recent initiates in the UK around the introduction of biosimilars in cancer; national dose banding of chemotherapy; and a radical approach to managing oral chemotherapy treatments.

dont miss

Medicine Optimisation in Oncology. How to achieve best value.

Expenditure on the drugs we use in cancer is increasing every year. This is a function of both demographics and a paradigm shift in how we treat cancer. It is therefore extremely important that we optimise the use of cancer medicines and eliminate waste.

EVEN MORE SEMINARS

  • Nizar Asadi: Speaking at the Oncology Convention

    Nizar Asadi
    Royal Brompton & Harefield NHS Foundation Trust

    Thoracic surgery in the treatment of lung cancer

  • Sam Janes: Speaking at the Oncology Convention

    Sam Janes
    UCL

    Early Detection of Lung Cancer

  • Michael Schreiber: Speaking at the Oncology Convention

    Michael Schreiber
    Brain Tumor Foundation, Chairman

    Brain Tumors - Innovation, support and advocacy

  • Professor Alex Mirnezami: Speaking at the Oncology Convention

    Professor Alex Mirnezami
    University of Southampton

    Biomarkers of Epithelial to Mesenchymal Transition and their clinical relevance in colorectal cancer

  • Mr Naga Venkatesh Jayanthi MD, FRCS: Speaking at the Oncology Convention

    Mr Naga Venkatesh Jayanthi MD, FRCS
    Bupa - Consultant Surgeon

    Minimal Invasive Oesophagectomy – where are we going?